Title : Talazoparib: First Global Approval.

Pub. Date : 2018 Dec

PMID : 30506138






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This article summarizes the milestones in the development of talazoparib leading to its first approval for the treatment of adults with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative, locally advanced or metastatic breast cancer. talazoparib BRCA1 DNA repair associated Homo sapiens